UnknownNot Applicable

COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS

Israel100 participantsStarted 2021-04-26

Plain-language summary

The aim of this study is to check for the presence of COVID 19 antibodies \[Covid-19, GAD-65, IA-2, ICA\] in the blood of laboring women who have been exposed to either the virus itself or to the vaccine during pregnancy . The same test will be done on cord blood. Then the types of antibodies will be compared, between maternal and neonatal blood. The blood will be taken along with routine blood tests without additional punctures of Mother or Baby.

Who can participate

Age range18 Years – 48 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * exposure to the COVID 19 virus or vaccine during pregnancy Exclusion Criteria: \- Age under 18 or over 48 IUFD

What they're measuring

Presence of anti COVID 19 antibodies in maternal and cord blood

Timeframe: ONE YEAR

Trial details

NCT IDNCT04860908

SponsorMaaynei Hayesha Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-01

Contact for this trial

Mirra Manevich, MD

0526001068 mirra.manevich@gmail.com

View on ClinicalTrials.gov More Generation of Anti COVID-19 Antibodies in a Fetus, Whose Mother Was Exposed to COVID or Was Vaccinated During Pregnancy trials